185 related articles for article (PubMed ID: 18354392)
1. Future suicide attempt and responses to serotonergic challenge.
Keilp JG; Oquendo MA; Stanley BH; Burke AK; Cooper TB; Malone KM; Mann JJ
Neuropsychopharmacology; 2010 Apr; 35(5):1063-72. PubMed ID: 18354392
[TBL] [Abstract][Full Text] [Related]
2. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
Cleare AJ; Murray RM; O'Keane V
Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.
Oquendo MA; Placidi GP; Malone KM; Campbell C; Keilp J; Brodsky B; Kegeles LS; Cooper TB; Parsey RV; van Heertum RL; Mann JJ
Arch Gen Psychiatry; 2003 Jan; 60(1):14-22. PubMed ID: 12511168
[TBL] [Abstract][Full Text] [Related]
4. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
Prochazka H; Sjögren M; Agren H
J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
[TBL] [Abstract][Full Text] [Related]
5. Prolactin response to fenfluramine and suicide attempt lethality in major depression.
Malone KM; Corbitt EM; Li S; Mann JJ
Br J Psychiatry; 1996 Mar; 168(3):324-9. PubMed ID: 8833686
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP
Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
O'Keane V; Dinan TG
Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and serotonin indices in depressed and suicidal patients.
Sarchiapone M; Camardese G; Roy A; Della Casa S; Satta MA; Gonzalez B; Berman J; De Risio S
J Affect Disord; 2001 Feb; 62(3):217-9. PubMed ID: 11223109
[TBL] [Abstract][Full Text] [Related]
9. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025
[TBL] [Abstract][Full Text] [Related]
10. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
Park SB; Williamson DJ; Cowen PJ
Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
[TBL] [Abstract][Full Text] [Related]
11. Blunted prolactin response to D-fenfluramine in post-stroke major depression.
Morris P; Hopwood M; Maguire K; Norman T; Schweitzer I
J Affect Disord; 2003 Sep; 76(1-3):273-8. PubMed ID: 12943959
[TBL] [Abstract][Full Text] [Related]
12. Hormonal responses to fenfluramine in depressed and control subjects.
Mitchell P; Smythe G
J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
[TBL] [Abstract][Full Text] [Related]
13. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
Mulder RT; Porter RJ; Joyce PR
J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
[TBL] [Abstract][Full Text] [Related]
14. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
[TBL] [Abstract][Full Text] [Related]
15. Blunted serotonergic responsivity in depressed inpatients.
Mann JJ; McBride PA; Malone KM; DeMeo M; Keilp J
Neuropsychopharmacology; 1995 Aug; 13(1):53-64. PubMed ID: 8526971
[TBL] [Abstract][Full Text] [Related]
16. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients.
Weizman A; Mark M; Gil-Ad I; Tyano S; Laron Z
Clin Neuropharmacol; 1988 Jun; 11(3):250-6. PubMed ID: 2969772
[TBL] [Abstract][Full Text] [Related]
17. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
Rajewska J; Rybakowski JK
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
[TBL] [Abstract][Full Text] [Related]
18. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
Maes M; Jacobs MP; Suy E; Minner B; Raus J
Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
[TBL] [Abstract][Full Text] [Related]
19. Higher cortisol levels in spring and fall in patients with major depression.
Sher L; Oquendo MA; Galfalvy HC; Zalsman G; Cooper TB; Mann JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):529-34. PubMed ID: 15866354
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior.
Coccaro EF; Siever LJ; Klar HM; Maurer G; Cochrane K; Cooper TB; Mohs RC; Davis KL
Arch Gen Psychiatry; 1989 Jul; 46(7):587-99. PubMed ID: 2735812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
